Viewing Study NCT02288234

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-25 @ 2:31 AM
Ignite Modification Date: 2026-03-13 @ 9:44 PM
Study NCT ID: NCT02288234
Status: COMPLETED
Last Update Posted: 2019-01-15
First Post: 2014-11-05
Is Gene Therapy: True
Has Adverse Events: False
Brief Title: Telavancin Observational Use Registry (TOUR)
Sponsor: Cumberland Pharmaceuticals
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Hospital Acquired Bacterial Pneumonia View
None Complicated Skin and Skin Structure Infections View
None Ventilator Associated Bacterial Pneumonia View
None Gram Positive Infection View
Keywords:

Keywords

Keyword Brief Keyword Text View
None Registry View